Fig. 5

Kaplan–Meier recurrence-free survival (RFS) analyses of the low-risk and high-risk groups in the PSS. The high-risk group patients had a significantly worse RFS than the low-risk groups patients in both the primary cohort (A) and validation cohort (B)